Last reviewed · How we verify

Cephalotin — Competitive Intelligence Brief

Cephalotin (cefalotin) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: cefalotin. Area: Metabolic.

marketed cefalotin Solute carrier family 22 member 8 Metabolic Live · refreshed every 30 min

Target snapshot

Cephalotin (cefalotin) — Eli Lilly.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Cephalotin TARGET cefalotin Eli Lilly marketed cefalotin Solute carrier family 22 member 8 1974-01-01
Benzoyl-Beta-Alanine BETAMIPRON marketed betamipron Solute carrier family 22 member 6, Solute carrier family 22 member 8

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (cefalotin class)

  1. Eli Lilly · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cephalotin — Competitive Intelligence Brief. https://druglandscape.com/ci/cefalotin. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: